What's new? Log in Free sign up

Table search / Allarity Therapeutics, Inc. / "Bonus"

8 results

Newest first Best match first

ALLR Allarity Therapeutics, Inc.

Definitive proxy

The following table provides information regarding total compensation awarded to, earned by, and paid to our named executive officers as of December 31, 2023, for services rendered to us in all capacities for the fiscal years ended December 31, 2023 and 2022. No option awards were granted to our named executive officers under our 2021 Plan during the fiscal years ended December 31, 2023 and 2022.

Name and Principal Position		Year		Salary*			Bonus(1)*			All Other Compensation ($)*				Total*
Thomas H. Jensen(2)		2022		$	—		$	—		$	—			$	—
Chief Executive Officer, Corporate Secretary, and Senior Vice President, Investor Relations		2023		$	—		$	—		$	24,720	(3)		$	24,720

Joan Y. Brown		2022		$	180,000		$	—			—			$	180,000
Chief Financial Officer, Director of Financial Reporting		2023		$	250,000		$	—			—			$	250,000

Marie Foegh(4)		2022		$	340,309		$	—			—			$	340,309
Former Chief Medical Officer		2023		$	365,471		$	—			—			$	365,471

James G. Cullem,		2022		$	343,410		$	—			—			$	343,410
Former Chief Executive Officer and Former Chief Business Officer(5)		2023		$	405,492		$	50,000		$	68,320	(6)		$	523,812

Steen Knudsen		2022		$	372,426		$	—			—			$	372,426
Chief Scientific Officer		2023		$	266,215		$	—			—			$	266,215

1 Jul 24

4:47pm

ALLR Allarity Therapeutics, Inc.

Definitive proxy

As of the year ended December 31, 2023, we had an employment or consultancy agreement with each of the following named executive officers, Dr. Foegh and Ms. Brown. The employment or consultancy agreement with each of the following individuals provides for the initial annual base salary as of December 31, 2023, current base salary and bonus set forth below. With the departure of Mr. Cullem, our Board appointed Mr. Jensen to serve as our Chief Executive Officer, effective as of December 12, 2023, and our director. In connection with Mr. Jensen’s new position as Chief Executive Officer, we increased his consulting fees to $38,400 per month for an initial period of three months.

Named Executive Officers and Position		Annual Base Salary as of December 31, 2023 ($)*
Thomas H. Jensen, Chief Executive Officer(1)		$	460,800
James G. Cullem, Former Chief Executive Officer, Chief Business Officer(2)		$	350,000
Joan Y. Brown, Chief Financial Officer(3) and Director of Financial Reporting		$	250,000
Marie Foegh, Former Chief Medical Officer		$	331,200

1 Jul 24

4:47pm

ALLR Allarity Therapeutics, Inc.

Annual report (amended)

The following table provides information regarding total compensation awarded to, earned by, and paid to our named executive officers as of December 31, 2023, for services rendered to the Company in all capacities for the fiscal years ended December 31, 2023 and 2022. No option awards were granted to our named executive officers under our 2021 Plan during the fiscal years ended December 31, 2023 and 2022.

Name and Principal Position		Year		Salary*				Bonus(1)*				All Other Compensation ($)*				Total*
Thomas H. Jensen(2)		2022		$	—			$	—			$	—			$	—
Chief Executive Officer, Corporate Secretary, and Senior Vice President, Investor Relations		2023		$	—			$	—			$	24,720	(3)		$	24,720

Joan Y. Brown		2022		$	180,000			$	—				—			$	180,000
Chief Financial Officer, Director of Financial Reporting		2023		$	250,000			$	—				—			$	250,000

Marie Foegh(4)		2022		$	340,309			$	—				—			$	340,309
Former Chief Medical Officer		2023		$	365,471			$	—				—			$	365,471

James G. Cullem,		2022		$	343,410			$	—				—			$	343,410
Former Chief Executive Officer and Former Chief Business Officer(5)		2023		$	405,492			$	50,000			$	68,320	(6)		$	523,812

Steen Knudsen		2022		$	372,426			$	—				—			$	372,426
Chief Scientific Officer		2023		$	266,215			$	—				—			$	266,215

ALLR Allarity Therapeutics, Inc.

Annual report (amended)

As of the year ended December 31, 2023, we had an employment or consultancy agreement with each of the following named executive officers, Ms. Foegh and Ms. Brown. The employment or consultancy agreement with each of the following individuals provides for the initial annual base salary as of December 31, 2023, current base salary and bonus set forth below. With the departure of Mr. Cullem, the Board of Directors appointed Mr. Jensen to serve as the Chief Executive Officer of the Company, effective as of December 12, 2023, and a director of the Company. In connection with Mr. Jensen’s new position as Chief Executive Officer, the Company increased his consulting fees to $38,400 per month for an initial period of three months.

Named Executive Officers and Position		Annual Base Salary as of December 31, 2023 ($)*

Thomas H. Jensen, Chief Executive Officer		$	460,800
James G. Cullem, Former Chief Executive Officer, Chief Business Officer(2)		$	350,000
Joan Y. Brown, Chief Financial Officer(3) and Director of Financial Reporting		$	250,000
Marie Foegh, Former Chief Medical Officer		$	331,200

ALLR Allarity Therapeutics, Inc.

IPO registration (amended)

As of the year ended December 31, 2023, we had an employment or consultancy agreement with each of the following named executive officers, Ms. Foegh and Ms. Brown. The employment or consultancy agreement with each of the following individuals provides for the initial annual base salary as of December 31, 2023, current base salary and bonus set forth below. With the departure of Mr. Cullem, the Board of Directors appointed Mr. Jensen to serve as the Chief Executive Officer of the Company, effective as of December 12, 2023, and a director of the Company. In connection with Mr. Jensen’s new position as Chief Executive Officer, the Company increased his consulting fees to $38,400 per month for an initial period of three months.

Named Executive Officers and Position		Annual Base Salary as of December 31, 2023 ($)*

Thomas H. Jensen, Chief Executive Officer		$	460,800
James G. Cullem, Former Chief Executive Officer, Chief Business Officer(2)		$	350,000
Joan Y. Brown, Chief Financial Officer(3) and Director of Financial Reporting		$	250,000
Marie Foegh, Former Chief Medical Officer		$	331,200

17 Apr 24

9:17am

q55 c1b2pxlh9bt1y0

IPO registration (amended)

17 Apr 24

9:17am

hhvt6wducaj 1eiad

IPO registration (amended)

5 Apr 24

6:26pm

IPO registration (amended)

5 Apr 24

6:26pm

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.